RecruitingPhase 3NCT07404865
Phase 3 Study of Telitacicept in Active Primary Sjögren's Disease
Sponsor: Vor Biopharma
Chicago, IL · Schaumburg, IL · Willowbrook, IL · +44 more sites
6 recruiting studies have a site in or near Schaumburg, IL, Illinois.
Showing 6 of 6 studies
Sponsor: Vor Biopharma
Chicago, IL · Schaumburg, IL · Willowbrook, IL · +44 more sites
Sponsor: Takeda
Orland Park, IL · Schaumburg, IL · +51 more sites
Sponsor: Hoffmann-La Roche
Gurnee, IL · Schaumburg, IL · Skokie, IL · +41 more sites
Sponsor: AstraZeneca
Champaign, IL · Chicago, IL · Gurnee, IL · +117 more sites
Sponsor: Exactech
Rockford, IL · Schaumburg, IL · +22 more sites
Sponsor: Ascletis Pharma (China) Co., Limited
Schaumburg, IL · +83 more sites
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.